Free Trial
OTCMKTS:SARTF

Sartorius Aktiengesellschaft (SARTF) Stock Price, News & Analysis

Sartorius Aktiengesellschaft logo
$192.75 0.00 (0.00%)
(As of 12/20/2024 ET)

About Sartorius Aktiengesellschaft Stock (OTCMKTS:SARTF)

Key Stats

Today's Range
$192.75
$192.75
50-Day Range
$183.28
$216.35
52-Week Range
$175.93
$313.00
Volume
N/A
Average Volume
147 shs
Market Capitalization
$6.60 billion
P/E Ratio
147.14
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Strong Buy

Company Overview

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers. It also provides live-cell analysis systems, reagents and consumables, support and services, and live-cell imaging and analysis software; contract manufacturing and integration, membranes and devices, weigh cells, and data analytics, as well as connectivity, and pipetting and dispensing modules; electronic and mechanical pipettes, pipette tips, bottle-top dispensers, and pipette controllers and accessories; process automation platform and software, sensors and analyzers, biomolecule analysis tools, and data analytics software; chromatography consumables, columns, and systems; and biolayer interferometry products. In addition, the company offers water purification systems; surface plasmon resonance; lab balances, pipette calibration, mass comparators and metrology, moisture analyzers, equipment manufacturer cells, weights and weight sets, paint mixing solutions, and weighing accessories; and process filtration. Further, the company provides bioprocess consulting and engineering, biologics testing, media and process, instrument, octet service and support, and validation services. It serves the life science research, biopharmaceutical manufacturing, pharmaceutical quality control, cell and gene therapy, and applied industries. Sartorius Aktiengesellschaft was founded in 1870 and is headquartered in Göttingen, Germany.

Receive SARTF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sartorius Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter.

SARTF Stock News Headlines

Sartorius 9-month Underlying Net Profit Declines; Confirms 2024 Guidance
Sartorius vz earnings: here's what Wall Street expects
Vladimir Lenin was right…
The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.
See More Headlines

SARTF Stock Analysis - Frequently Asked Questions

Sartorius Aktiengesellschaft's stock was trading at $285.04 at the beginning of 2024. Since then, SARTF shares have decreased by 32.4% and is now trading at $192.75.
View the best growth stocks for 2024 here
.

Sartorius Aktiengesellschaft (OTCMKTS:SARTF) announced its quarterly earnings results on Thursday, October, 17th. The company reported $0.96 earnings per share (EPS) for the quarter. The company had revenue of $872.19 million for the quarter. Sartorius Aktiengesellschaft had a trailing twelve-month return on equity of 7.69% and a net margin of 2.50%.

Sartorius Aktiengesellschaft subsidiaries include Novasep’s chromatography division, ALS Automated Lab Solutions GmbH, Xell AG, CellGenix Inc., WaterSep BioSeparations LLC, BIA Separations, Biological Industries, and others.

Shares of SARTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

Last Earnings
10/17/2024
Today
12/21/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Dental equipment & supplies
Sub-Industry
N/A
Current Symbol
OTCMKTS:SARTF
Previous Symbol
NASDAQ:SARTF
CIK
N/A
Employees
14,614
Year Founded
1870

Profitability

Net Income
$221.98 million
Pretax Margin
5.94%

Debt

Sales & Book Value

Annual Sales
$3.67 billion
Cash Flow
$29.03 per share
Book Value
$81.84 per share

Miscellaneous

Free Float
N/A
Market Cap
$6.60 billion
Optionable
Not Optionable
Beta
1.01

Social Links

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report

This page (OTCMKTS:SARTF) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners